BIOLEAP, LLC

Basic Information

238 W. Delaware Ave
Pennington, NJ, 08534-1603

Company Profile

n/a

Additional Details

Field Value
DUNS: 963172569
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel ex-vivo Immunoadsorption Therapy to Treat Preeclampsia

    Amount: $216,678.00

    DESCRIPTION: Recent phase II clinical studies demonstrate that an antibody targeting proportion convertase subtilisin/kexin type 9 (PCSK9)-a target for the treatment of hypercholesterolemia and coron ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government